ENDRA Life Sciences Beat Consensus Estimates
Thursday, May 15, 2025 at 4:05 PM ET
ENDRA Life Sciences (NDRA) reported a loss of $2.59 per share on revenue of $0.00 million for the first quarter ended March 2025. The consensus estimate was a loss of $3.91 per share on revenue of $0.01 million. The company beat consensus estimates by 33.76%.
ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.
Earnings Whisper Grade
Power Rating
-
-
Reported Earnings
$-2.59
Earnings Whisper®
-
Consensus Estimate
$-3.91
Earnings Surprise
Earnings Growth
Reported Revenue
-
Revenue Estimate
$10.00 Thou
Revenue Surprise
Revenue Growth